The inflammatory component of Kaposi sarcoma

被引：10
作者：
Pantanowitz, Liron [1 ]
Moses, Ashlee V. [2 ]
Dezube, Bruce J. [3 ]
机构：
[1] Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA
[2] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA
[3] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Sch Med, Boston, MA 02215 USA
来源：
EXPERIMENTAL AND MOLECULAR PATHOLOGY | 2009年 / 87卷 / 02期
关键词：
Inflammation; Immunity; Dendritic cell; KSHV; HHV8; Granuloma; DERMAL DENDROCYTES; DENDRITIC CELLS; PATHOGENESIS; AIDS;
D O I：
10.1016/j.yexmp.2009.07.001
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Kaposi sarcoma (KS) is intimately linked to several aspects of the host immune system. KS development is linked to immunodeficiency in several clinical-epidemiological settings. The development of KS at local inflammatory sites has also been documented. Inflammatory cells are almost always present within KS lesions. Depending upon the inflammatory milieu, KS lesions may progress or regress. Not surprisingly, iatrogenic manipulation of host immunity with drugs may provoke KS growth and/or flare. Given the close association between KS and the immune system, the etiologic agent Kaposi Sarcoma Herpesvirus has developed a variety of mechanisms to evade the host immune system, all of which have cleverly evolved to promote oncogenesis and viral persistence. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码：163 / 165
页数：3
相关论文
共 26 条
  • [1] Bedani PL, 1999, J NEPHROL, V12, P193
  • [2] Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma
    Bower, M
    Nelson, M
    Young, AM
    Thirlwell, C
    Newsom-Davis, T
    Mandalia, S
    Dhillon, T
    Holmes, P
    Gazzard, BG
    Stebbing, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5224 - 5228
  • [3] SARCOID REACTIONS IN MALIGNANT-TUMORS
    BRINCKER, H
    [J]. CANCER TREATMENT REVIEWS, 1986, 13 (03) : 147 - 156
  • [4] Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma
    Brown, Elizabeth E.
    Whitby, Denise
    Vitale, Francesco
    Marshall, Vickie
    Mbisa, Georgina
    Gamache, Christine
    Lauria, Carmela
    Alberg, Anthony J.
    Serraino, Diego
    Cordiali-Fei, Paola
    Messina, Angelo
    Goedert, James J.
    [J]. CANCER, 2006, 107 (09) : 2282 - 2290
  • [5] Progression of classic Kaposi's sarcoma with rituximab
    Clifford, KS
    Demierre, MF
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 53 (01) : 155 - 157
  • [6] ORIGIN OF KAPOSIS SARCOMA FROM RETICULO-ENDOTHELIAL SYSTEM
    DAYAN, AD
    LEWIS, PD
    [J]. NATURE, 1967, 213 (5079) : 889 - &
  • [7] Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma
    Della Bella, Silvia
    Nicola, Stefania
    Brambilla, Lucia
    Riva, Antonio
    Ferrucci, Silvia
    Presicce, Pietro
    Boneschi, Vinicio
    Berti, Emilio
    Villa, Maria Luisa
    [J]. CLINICAL IMMUNOLOGY, 2006, 119 (03) : 317 - 329
  • [8] Dezube BJ, 2000, SEMIN ONCOL, V27, P420
  • [9] Douglas JL, 2007, PANMINERVA MED, V49, P119
  • [10] Cutaneous cryptococcosis and Kaposi's sarcoma occurring in the same lesions in a patient with the acquired immunodeficiency syndrome
    Glassman, SJ
    Hale, MJ
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 1995, 20 (06) : 480 - 486
123